FEDERATED HERMES, INC. - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$6,000
-99.1%
348
-99.3%
0.00%
-100.0%
Q4 2021$668,000
-94.6%
48,241
-94.4%
0.00%
-95.8%
Q3 2021$12,475,000
+5.6%
868,137
+16.2%
0.02%
+9.1%
Q2 2021$11,810,000
+4568.0%
746,971
+2898.2%
0.02%
Q1 2021$253,000
+25200.0%
24,914
+15091.5%
0.00%
Q4 2020$1,000
-99.9%
164
-100.0%
0.00%
-100.0%
Q3 2019$949,000
-58.8%
331,172
-45.6%
0.00%
-66.7%
Q2 2019$2,306,000
-63.7%
608,316
-22.0%
0.01%
-62.5%
Q1 2019$6,344,000
+80.2%
779,406
+78.7%
0.02%
+60.0%
Q4 2018$3,520,000
+31900.0%
436,137
+31481.2%
0.01%
Q3 2018$11,000
-97.1%
1,381
-98.0%
0.00%
-100.0%
Q2 2017$385,000
-81.8%
69,320
-72.5%
0.00%
-83.3%
Q1 2017$2,117,000
+298.7%
252,060
+200.7%
0.01%
+200.0%
Q4 2016$531,000
+48.7%
83,835
+3.7%
0.00%
+100.0%
Q3 2016$357,000
+20.2%
80,852
-22.7%
0.00%0.0%
Q2 2016$297,000
+2870.0%
104,574
+10357.4%
0.00%
Q4 2015$10,0001,0000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders